Patent · US Active

Angiotensin II receptor antagonists

US8053455B2 · kind B2 · utility

1Cited by

2References

20Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Amjad Ali · Freehold, US
Michael Man-Chu Lo · Rahway, US
Christopher Franklin · Keasbey, US
Brent Whitehead · Piscataway, US

Key dates

Filing date	Apr 25, 2011
Grant date	Nov 8, 2011
Priority date	—
Expiry date	Apr 25, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound having the structurewherein R is an angiotensin receptor antagonist active group, and—C(R1H)OC(O)X((CR12R13)—(CHR10)m—(CH2)n—Zp—(CH2)q—(CHR11)r—(CR16R17))—R5; 2)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.